Higher avidity binding of apolipoprotein (E-AII) complex than of apolipoprotein E monomer to β-amyloid

Journal of Neuroscience Research

Volumn 58, Issue 2, 1999, Pages 301-307

  Yamauchi, Kazuyoshi ^a   Tozuka, Minoru ^a   Nakabayashi, Tetsuo ^a   Sugano, Mitsutoshi ^a   Hidaka, Hiroya ^a   Kondo, Yoshiyuki ^b   Katsuyama, Tsutomu ^c  

^a SHINSHU UNIVERSITY HOSPITAL   (Japan)

^b SHINSHU UNIVERSITY   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alzheimer's disease; Apolipoprotein E; Cerebrospinal fluid; Disulfide linked complex; Enzyme linked immunosorbent assay

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN; APOLIPOPROTEIN E;

ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID EXAMINATION; CHEMICAL BINDING; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; NORMAL HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING;

AMYLOID BETA-PROTEIN; APOLIPOPROTEIN A-II; APOLIPOPROTEINS E; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOBLOTTING; PROTEIN BINDING; RISK FACTORS;

EID: 0033569717     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19991015)58:2<301::AID-JNR10>3.0.CO;2-9     Document Type: Article

References (29)

1. Bales KR, Verina T, Dodel RC, Du Y, Altstiel L, Bender M, Hyslop P, Johnstone EM, Little SP, Cummins DJ, Piccardo P, Ghetti B, Paul SM. 1997. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nature Genet 17:263-264.
2. Beisiegel U, Weber W, Ihrke G, Herz J, Stanley KK. 1989. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature 341:162-164.
3. Boyles JK, Zoellner CD, Anderson LJ, Kosik LM, Pitas RE, Weisgraber KH, Hui DY, Mahley RW, Gebicke-Haerter PJ, Ignatius MJ, Shooter EM. 1989. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 83:1015-1031.
4. Carlsson J, Armstrong VW, Reiber H, Felgenhauer K, Seidel D. 1991. Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid. Clin Chim Acta 196:167-176.
5. Castano EM, Prelli F, Frangione B. 1995. Apolipoprotein E carboxyl-terminal fragments are complexed to amyloids A and L. Implications for amyloidogenesis and Alzheimer's disease. J Biol Chem 270:17610-17615.
6. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923.
7. Diedrich JF, Minnigan H, Carp RI, Whitaker JN, Race R, Frey W 2nd, Haase AT. 1991. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol 65:4759-4768.
8. Elshourbagy NA, Liao WS, Mahley RW, Taylor JM. 1985. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc Natl Acad Sci USA 82:203-207.
9. Jarrett JT, Lansbury PT Jr. 1993. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73:1055-1058.
10. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B. 1987. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325:733-736.
11. LaDu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE. 1994. Isoform-specific binding of apolipoprotein E to β-amyloid. J Biol Chem 269:23403-23406.
12. LaDu MJ, Gilligan SM, Lukens JR, Cabana VG, Reardon CA, Van Eldik LJ, Holtzman DM. 1998. Nascent astrocyte particles differ from lipoproteins in CSF. J Neurochem 70:2070-2081.
13. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
14. Mahley RW. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622-630.
15. Martel CL, Mackic JB, Matsubara E, Governale S, Miguel C, Miao W, McComb JG, Frangione B, Ghiso J, Zlokovic BV. 1997. Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid β. J Neurochem 69:1995-2004.
16. Montine KS, Bassett CN, Ou JJ, Markesbery WR, Swift LL, Montine TJ. 1998. Apolipoprotein E allelic influence on human cerebrospinal fluid apolipoproteins. J Lipid Res 39:2443-2451.
17. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. 1991. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 541:163-166.
18. Noguchi S, Murakami K, Yamada N. 1993. Apolipoprotein E genotype and Alzheimer's disease. Lancet 342:737.
19. Rebeck GW, Alonzo NC, Berezovska O, Harr SD, Knowles RB, Growdon JH, Hyman BT, Mendez AJ. 1998. Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different ApoE genotypes. Exp Neurol 149:175-182.
20. Roher AE, Lowenson JD, Clarke S, Wolkow C, Wang R, Cotter RJ, Reardon IM, Zurcher-Neely HA, Heinrikson RL, Ball MJ, Greenberg BD. 1993. Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem 268:3072-3083.
21. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD. 1993. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 90:9649-9653.
22. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. 1993a. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90:1977-1981.
23. Strittmatter WJ, Weisgraber KH, David Y, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD. 1993b. Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 90:8098-8102.
24. Tozuka M, Hidaka H, Miyachi M, Furihata K, Katsuyama T, Kanai M. 1992. Identification and characterization of apolipoprotein (AII-E2-AII) complex in human plasma lipoprotein. Biochim Biophys Acta 1165:61-67.
25. van Duijn CM, de Knijff P, Cruts M, Wehnert A, Havekes LM, Hofman A, Van Broeckhoven C. 1994. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nature Genet 7:74-78.
26. Weisgraber KH. 1990. Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. J Lipid Res 31:1503-1511.
27. Weisgraber KH, Mahley RW. 1978. Apoprotein (E-A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction. J Biol Chem 253:6281-6288.
28. Weisgraber KH, Shinto LH. 1991. Identification of the disulfide-linked homodimer of apolipoprotein E3 in plasma. Impact on receptor binding activity. J Biol Chem 266:12029-12034.
29. Yamauchi K, Tozuka M, Nakabayashi T, Sugano M, Hidaka H, Kondo Y, Katsuyama T. 1999. Apolipoprotein E in cerebrospinal fluid: relation to phenotype and plasma apolipoprotein E concentrations. Clin Chem 45:497-504.